XML 35 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Total Jacobs Stockholders’ Equity
Total Jacobs Stockholders’ Equity
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-in Capital
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Noncontrolling Interests
Balance at the beginning of the period at Sep. 28, 2018 $ 5,944,354 $ (37,209) $ 5,854,345 $ (37,209) $ 142,218 $ 2,708,839 $ 3,809,991 $ (37,209) $ (806,703) $ 90,009
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net earnings 873,219   847,979       847,979     25,240
Disposition of ECR business, net of deferred taxes 67,037   112,764           112,764 (45,727)
Foreign currency translation adjustments (84,456)   (84,456)           (84,456)  
Pension and retiree medical plan liability, net of deferred taxes (139,218)   (139,218)           (139,218)  
(Loss) Gain on derivatives, net of deferred taxes 801   801           801  
Noncontrolling interest acquired/consolidated (1,113)   (1,113)     (1,113)        
Dividends (92,980)   (92,980)       (92,980)      
Noncontrolling interests - distributions and other (15,555)   0       0     (15,555)
Stock based compensation 69,137   69,137     69,128 9      
Issuances of equity securities including shares withheld for taxes 38,317   38,317   1,681 43,508 (6,872)      
Repurchases of equity securities (853,676)   (853,676)   (11,020) (260,912) (581,744)      
Balance at the end of the period at Sep. 27, 2019 5,768,658   5,714,691   132,879 2,559,450 3,939,174   (916,812) 53,967
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net earnings 523,867   491,845       491,845     32,022
Foreign currency translation adjustments 60,330   60,330           60,330 0
Pension and retiree medical plan liability, net of deferred taxes (61,977)   (61,977)           (61,977)  
(Loss) Gain on derivatives, net of deferred taxes (14,598)   (14,598)           (14,598)  
Dividends (99,921)   (99,921)       (99,921)      
Noncontrolling interests - distributions and other (41,032)   5,002     5,002       (46,034)
Stock based compensation 48,150   48,150     47,048 1,102      
Issuances of equity securities including shares withheld for taxes 9,441   9,441   998 17,890 (9,447)      
Repurchases of equity securities (337,251)   (337,251)   (4,129) (30,944) (302,178)      
Balance at the end of the period at Oct. 02, 2020 5,855,667   5,815,712   129,748 2,598,446 4,020,575   (933,057) 39,955
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net earnings 430,829                  
Net earnings 516,243   477,030       477,030     39,213
Foreign currency translation adjustments 12,475   12,475           12,475  
Pension and retiree medical plan liability, net of deferred taxes 104,165   104,165           104,165  
(Loss) Gain on derivatives, net of deferred taxes 21,975   21,975           21,975  
Dividends (109,616)   (109,616)       (109,616)      
Noncontrolling interests - distributions and other (44,372)                 (44,372)
Redeemable Noncontrolling interests redemption value adjustment (175,183)   (175,183)       (175,183)      
Stock based compensation 56,221   56,221     56,221 0      
Issuances of equity securities including shares withheld for taxes 12,210   12,210   871 20,345 (9,006)      
Repurchases of equity securities (274,948)   (274,948)   (1,726) (85,000) (188,222)      
Balance at the end of the period at Oct. 01, 2021 $ 5,974,837   $ 5,940,041   $ 128,893 $ 2,590,012 $ 4,015,578   $ (794,442) $ 34,796